AZILECT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug AZILECT contains one active pharmaceutical ingredient (API):

1	Rasagiline UNII LH8C2JI290 - RASAGILINE MESYLATE
	Rasagiline was shown to be a potent, irreversible MAO-B selective inhibitor, which may cause an increase in extracellular levels of dopamine in the striatum. The elevated dopamine level and subsequent increased dopaminergic activity are likely to mediate rasagiline’s beneficial effects seen in models of dopaminergic motor dysfunction.
	Read more about Rasagiline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BD02	Rasagiline	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BD Monoamine oxidase B inhibitors
Discover more medicines within N04BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1952R
BR	Câmara de Regulação do Mercado de Medicamentos	537500802115219, 537517110007003
CA	Health Products and Food Branch	02284642, 02284650
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00275748, 00285758, 00559641, 01686910, 03103189, 03104409, 03442744, 03887251, 03887274, 05351833, 05500500, 05500517, 07264920, 07337576, 07337582, 09695340, 09695357, 10060925, 10167586, 10201610, 10989578, 10989584, 12146097, 12368745, 14178411, 15612476, 16151190
EE	Ravimiamet	1203400, 1203411, 1203422, 1203433, 1203444, 1203455
ES	Centro de información online de medicamentos de la AEMPS	04304004, 04304004IP1, 04304004IP2, 04304004IP3, 04304004IP4, 04304004IP5
FI	Lääkealan turvallisuus- ja kehittämiskeskus	084406
FR	Base de données publique des médicaments	62722988
GB	Medicines & Healthcare Products Regulatory Agency	374303, 376213, 381189, 93627
HK	Department of Health Drug Office	60594
IE	Health Products Regulatory Authority	13115, 13166, 31802, 31808
IL	מִשְׂרַד הַבְּרִיאוּת	4803
IT	Agenzia del Farmaco	036983029
JP	医薬品医療機器総合機構	1169017F1025, 1169017F2021
LT	Valstybinė vaistų kontrolės tarnyba	1005647, 1026350, 1026351, 1026353, 1026354, 1026355, 1026356
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	156M2006
NL	Z-Index G-Standaard, PRK	78891
PL	Rejestru Produktów Leczniczych	100105492
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62982001, W62982002, W62982003, W62982004, W62982006, W62982008, W62982009
SG	Health Sciences Authority	15291P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699638015313, 8699638015450
US	FDA, National Drug Code	68546-142, 68546-229
ZA	Health Products Regulatory Authority	41/5.4.1/0781